| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| LANREOTIDE
| LANREOTIDE | HORMONES | SUBCUTANEOUS | Cmax 5.7 NANOMOLAR Tmax 9.5 HOUR F 78.4 PERCENT (120 MILLIGRAM) VD 13 LITER (65 KILOGRAM) PPB 81 PERCENT Cl 23.7 LITER / HOUR HT 636 HOUR | SOMATOSTATIN RECEPTORS (SSTR) 2 AND 5 REDUCED BINDING AFFINITY FOR HUMAN SSTR1, 3, AND 4 | Somatostatin receptor type 2 UNIPROT P30874 SSTR2 -- Somatostatin receptor type 5 UNIPROT P35346 SSTR5 more at DrugCentral | EMA | |||
